6 days remaining
CARE - THE FUTURE OF HEALTH - (ROUND 2)
care is Switzerland's leading healthtech company for prevention. More than 10,000 customers use the platform, which combines diagnostics, telemedicine and doctor-supervised weight-loss programmes with its own mobile app and clinical software. With profitability targeted from 2027, care is now opening the last opportunity to invest via the crowd, before the next larger financing round or an exit.
480 CHF
Minimum amount
700.000 CHF
Funding target
480 CHF
6,40 CHF
6 days remaining
Magic Heidi - Invoicing and accounting for Swiss self-employed professionals
Hundreds of thousands of self-employed professionals in Switzerland manage their accounts using Excel and receipts kept in a shoebox. Magic Heidi replaces this with one application in all four national languages - on iPhone, Android, Mac, Windows and the web. More than 750 paying customers and over CHF 200,000 in annual recurring revenue demonstrate the demand.
345 CHF
Minimum amount
250.010 CHF
Funding target
345 CHF
23,00 CHF
-campaignThumbnailFallback.jpg)
20 days remaining
4Fondue AG - A must-have that enriches life in every home!
“Why didn’t anyone think of this sooner?” With our patented 4FONDUE pan, we’ve developed one of the most versatile pans of our time, designed to reinvent moments of togetherness at home. Whether it’s a classic fondue, a fun pasta dinner, a hot pot, or simply an induction pan for everyday use: one pan. Countless possibilities. A must-have for every home. Now a new chapter begins: you can become a shareholder and be part of our growth. Over 200 million households in Europe—and we’re just getting started.
14 CHF
Issue price
200.000 CHF
Funding target
1 month remaining
AYUN - Clinic for Personalized Preventive and Longevity Medicine
AYUN combines comprehensive medical diagnostics with personalized interventions and measurable outcomes. More than 1,500 clients have already used the Zurich-based longevity and preventive medicine clinic. The crowdfunding investment round aims to further scale the established model and finance the next phase of growth.
12 CHF
Issue price
750.000 CHF
Funding target
Starting soon
AVEA - Longevity Science from Switzerland
We make longevity science accessible to everyone: our innovative supplements support healthy ageing at the cellular level. Since 2022 we have reached well over 250,000 people and built a profitable core business with excellent unit economics. Now we are raising capital to roll out our recipe for success to further European markets and lay the foundation for entering the USA.
100.000 CHF
Financing threshold
1.000.000 CHF
Funding target
Successfully financed
ONESTO – Built for the Next Stage of Growth
After successfully establishing the brand in Switzerland and launching Germany, ONESTO is entering its next growth phase. This financing round will support international expansion, market development and scaling. Investors have the opportunity to join a proven business at the beginning of its next chapter.
297.119
Invested
Successfully financed
Calingo - Pet insurance made simple
Calingo is Switzerland’s first modern, digital pet insurance. We help pet parents protect their furry friends and actively support their health.More than 12,000 dogs and cats are already insured with us. Become a co-owner, join us on our journey to becoming the market leader, and help actively shape the future of pet health.
1.369.160
Invested
-campaignThumbnailFallback.jpg)
Successfully financed
Oakwood Capital - More than Bitcoin.
Oakwood Capital connects Bitcoin with established financial structures – regulated, transparent, and with real skin in the game. We don't just develop, we implement ourselves: our own Bitcoin balance sheet, our own mining infrastructure. For investors who want more than just theory. Become part of this vision now.
72.116
Invested
Successfully financed
KA-EX® - Bioactive Substances for Athletes
KA-EX is a leading Swiss functional nutrition company with patented technology and international scale. Following its strong market position in Switzerland and successful launch in the US, KA-EX is opening its Pre-Series B as the last investment opportunity for private investors to finance the next phase of growth before Series B.
4.581.900
Invested
-campaignThumbnailFallback.jpg)
-campaignThumbnailFallback.jpg)
.ai-(4)-issuerCompanyLogoFallback.jpg){kind=logo}
-campaignThumbnailFallback.jpg)
-campaignThumbnailFallback.jpg)
-campaignThumbnailFallback.jpg)
